• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Callan JMB Inc. filed SEC Form 8-K: Regulation FD Disclosure

    1/27/26 5:10:11 PM ET
    $CJMB
    Real Estate
    Real Estate
    Get the next $CJMB alert in real time by email
    false 0002032545 0002032545 2026-01-27 2026-01-27 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

     

    FORM 8-K

     

    CURRENT REPORT

    PURSUANT TO SECTION 13 OR 15(d) OF

    THE SECURITIES EXCHANGE ACT OF 1934

     

    Date of Report (Date of earliest event reported): January 27, 2026

     

    Callan JMB Inc.

    (Exact name of registrant as specified in its charter)

     

    Nevada   001-42506   99-0931141
    (State or other jurisdiction   (Commission   (I.R.S. Employer
    of incorporation)   File Number)   Identification No.)

     

    244 Flightline Drive    
    Spring Branch, Texas   78070
    (Address of principal executive offices)   (Zip Code)

     

    Registrant’s telephone number, including area code: (830) 438-0395

     

    N/A

    (Former name or former address, if changed since last report)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
       
    ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
       
    ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
       
    ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class   Trading Symbol(s)   Name of each exchange on which registered
    Common Stock, $0.001 par value   CJMB   The Nasdaq Stock Market LLC

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

     

    Emerging growth company ☒

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     

     

     

     

     

    Item 7.01. Regulation FD Disclosure.

     

    Beginning on January 28, 2026, Callan JMB Inc., a Nevada corporation (the “Company”) plans to make a series of investor presentations (the “Investor Presentation”) at the DealFlow Discovery Conference. The Company also expects to use the Investor Presentation from time to time thereafter in connection with presentations to potential investors, industry analysts and others. The Investor Presentation is available under “Investor Relations” section of the Company’s website, located at https://investors.callanjmb.com/.

     

    A copy of the Investor Presentation is also attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The Company anticipates that future investor presentations will routinely be made available both at the website location referenced above and through an Item 7.01 Current Report on Form 8-K.

     

    By filing this Current Report on Form 8-K and furnishing the information contained herein, the Company makes no admission as to the materiality of any information in this report or the Investor Presentation that is required to be disclosed solely by reason of Regulation FD.

     

    The information contained in the Investor Presentation is summary information that is intended to be considered in the context of the Company’s Securities and Exchange Commission (“SEC”) filings and other public announcements that the Company may make, by press release or otherwise, from time to time. The Company undertakes no duty or obligation to publicly update or revise the information contained in this report, although it may do so from time to time as its management believes is warranted. Any such updating may be made through the filing of other reports or documents with the SEC, through press releases or through other public disclosure.

     

    The information presented in Item 7.01 of this Current Report on Form 8-K and Exhibit 99.1 shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, unless the Company specifically states that the information is to be considered “filed” under the Exchange Act or specifically incorporates it by reference into a filing under the Securities Act of 1933, as amended, or the Exchange Act.

     

    Item 9.01 Financial Statements and Exhibits.

     

    (d) Exhibits. The following exhibits are filed with this Form 8-K:

     

    Exhibit No.   Description
    99.1   Callan JMB Inc. Investor Presentation
    104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

     

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

    Date: January 27, 2026 Callan JMB Inc.
         
      By: /s/ Wayne Williams
      Name: Wayne Williams
      Title: Chief Executive Officer

     

     

     

    Get the next $CJMB alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CJMB

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $CJMB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Dial Gerald bought $2,409 worth of shares (2,000 units at $1.20) (SEC Form 4)

    4 - CALLAN JMB INC. (0002032545) (Issuer)

    1/6/26 11:51:38 AM ET
    $CJMB
    Real Estate

    CEO, Chairman and President Williams Wayne D bought $8,650 worth of shares (5,000 units at $1.73) (SEC Form 4)

    4 - CALLAN JMB INC. (0002032545) (Issuer)

    12/18/25 7:54:01 PM ET
    $CJMB
    Real Estate

    CEO, Chairman and President Williams Wayne D bought $27,108 worth of shares (15,798 units at $1.72), increasing direct ownership by 0.22% to 2,267,488 units (SEC Form 4)

    4 - CALLAN JMB INC. (0002032545) (Issuer)

    12/15/25 8:14:20 PM ET
    $CJMB
    Real Estate

    $CJMB
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Callan JMB Announces Participation in the DealFlow Discovery Conference on January 28-29, 2026

    SPRING BRANCH, Texas, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Callan JMB Inc. (NASDAQ:CJMB), ("Callan JMB" or the "Company"), an integrative logistics company empowering the healthcare industry and emergency management agencies through fulfillment, storage, monitoring, and cold chain logistics services, today announced its participation in the DealFlow Discovery Conference on January 28-29, 2026. DealFlow Discovery ConferenceDates: January 28-29, 2026Location: The Borgata, Atlantic City, NJPresentation Details: Wednesday, January 28 at 3:00pm, in Room #3 For more information, please contact your DealFlow representative or email KCSA Strategic Communications at [email protected]. About Callan

    1/20/26 9:00:00 AM ET
    $CJMB
    Real Estate

    Callan JMB Signs Manufacturing Oversight, Federal Deployment, and Commercialization Agreement of Multi-Asset Therapeutic Pipeline with Attune for Approximately $50 to $75 Million in Total Revenue

    Partnership Leverages Callan JMB's Federal Contract Experience, Cold Chain Infrastructure, and Strategic National Stockpile Relationships to Enable Immediate Deployment Readiness SPRING BRANCH, TX, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Callan JMB Inc. (NASDAQ:CJMB), ("Callan JMB" or the "Company"), an integrative logistics company empowering the healthcare industry and emergency management agencies through fulfillment, storage, monitoring, and cold chain logistics services, today announced it has signed a strategic teaming agreement with Biostax Corp d/b/a Attune Biotech Inc. ("Attune"), a clinical-stage biopharmaceutical company with a diversified therapeutic pipeline. Callan JMB will serve

    1/15/26 8:45:00 AM ET
    $CJMB
    Real Estate

    Callan JMB Announces Third Quarter 2025 Financial Results and Provides Business Update

    Expanded the Company's compliance-driven logistics platform into the food sampling industryEntered agreement to install oral drug delivery equipment at Texas facility Established a subsidiary in India and advanced plans for a temperature-controlled pharmaceutical storage and distribution warehouseExtended the Company's long-term contract with the City of Chicago through June 2026, including an increase in funding Upgraded Sentry Monitoring System Technology with Sentry 4 for Mobile Temperature Monitoring SPRING BRANCH, Texas, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Callan JMB INC. (NASDAQ:CJMB) ("Callan JMB" or the "Company"), an integrative logistics company empowering the healthcare industry

    11/14/25 4:05:00 PM ET
    $CJMB
    Real Estate

    $CJMB
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Dial Gerald bought $2,409 worth of shares (2,000 units at $1.20) (SEC Form 4)

    4 - CALLAN JMB INC. (0002032545) (Issuer)

    1/6/26 11:51:38 AM ET
    $CJMB
    Real Estate

    CEO, Chairman and President Williams Wayne D bought $8,650 worth of shares (5,000 units at $1.73) (SEC Form 4)

    4 - CALLAN JMB INC. (0002032545) (Issuer)

    12/18/25 7:54:01 PM ET
    $CJMB
    Real Estate

    CEO, Chairman and President Williams Wayne D bought $27,108 worth of shares (15,798 units at $1.72), increasing direct ownership by 0.22% to 2,267,488 units (SEC Form 4)

    4 - CALLAN JMB INC. (0002032545) (Issuer)

    12/15/25 8:14:20 PM ET
    $CJMB
    Real Estate

    $CJMB
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Callan JMB Inc.

    SCHEDULE 13G/A - CALLAN JMB INC. (0002032545) (Subject)

    2/13/26 5:51:28 PM ET
    $CJMB
    Real Estate

    Callan JMB Inc. filed SEC Form 8-K: Regulation FD Disclosure

    8-K - CALLAN JMB INC. (0002032545) (Filer)

    1/27/26 5:10:11 PM ET
    $CJMB
    Real Estate

    Callan JMB Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - CALLAN JMB INC. (0002032545) (Filer)

    12/31/25 9:00:24 AM ET
    $CJMB
    Real Estate

    $CJMB
    Leadership Updates

    Live Leadership Updates

    View All

    Callan JMB Appoints Former Assistant Commissioner of Chicago Department of Health, Christopher Shields, as Senior Vice President of Emergency Preparedness & Response/Government Affairs

    Christopher Shields, an industry veteran who oversaw operations and logistics at the city of Chicago's Emergency Preparedness and Bioterrorism program, will focus on growing Callan JMB's emergency preparedness & response operations into new U.S. cities, states, and other countries. SPRING BRANCH, Texas, April 25, 2025 (GLOBE NEWSWIRE) -- Callan JMB INC. (NASDAQ:CJMB) ("Callan JMB" or the "Company"), an integrative logistics company empowering the healthcare industry and emergency management agencies through fulfillment, storage, monitoring, and cold chain logistics services, today announced the appointment of former Assistant Commissioner of the Chicago Department of Public Health, Christ

    4/25/25 9:00:00 AM ET
    $CJMB
    Real Estate

    $CJMB
    Financials

    Live finance-specific insights

    View All

    Callan JMB Announces Third Quarter 2025 Financial Results and Provides Business Update

    Expanded the Company's compliance-driven logistics platform into the food sampling industryEntered agreement to install oral drug delivery equipment at Texas facility Established a subsidiary in India and advanced plans for a temperature-controlled pharmaceutical storage and distribution warehouseExtended the Company's long-term contract with the City of Chicago through June 2026, including an increase in funding Upgraded Sentry Monitoring System Technology with Sentry 4 for Mobile Temperature Monitoring SPRING BRANCH, Texas, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Callan JMB INC. (NASDAQ:CJMB) ("Callan JMB" or the "Company"), an integrative logistics company empowering the healthcare industry

    11/14/25 4:05:00 PM ET
    $CJMB
    Real Estate

    Callan JMB Announces Second Quarter 2025 Financial Results and Provides Business Update

    Formed a strategic partnership with Revival Health Inc. ("Revival") to deliver fully integrated supply chain services and infrastructure to support both the importation and onshore manufacturing of health, wellness, and longevity products Launched subsidiary in India and progressed to establish temperature-controlled warehouse for storage and distribution of pharmaceuticals at all temperature ranges Extended long-term contract with City of Chicago and received increase in funding Appointed Christopher Shields, former Assistant Commissioner of the Chicago Department of Public Health, as Senior Vice President, Emergency Preparedness & Response/Government Affairs Supported Texas and New Mex

    8/14/25 4:30:00 PM ET
    $CJMB
    Real Estate

    Callan JMB Announces Full Year 2024 Financial Results and Provides Business Update

    Successfully Closed IPO on February 6, 2025, at $4.00 per Share for Gross Proceeds of Approximately $5.7 Million, Including Partial Exercise of Over-Allotment Option SPRING BRANCH, Texas, March 28, 2025 (GLOBE NEWSWIRE) -- Callan JMB INC. (NASDAQ:CJMB) ("Callan JMB" or the "Company"), an integrative logistics company empowering the healthcare industry and emergency management agencies through fulfillment, storage, monitoring, and cold chain logistics services, today announced its financial results for the full year ended December 31, 2024, and provided a business update. "2024 was a pivotal year for Callan JMB as we continued to deliver exceptional service to our diverse client base whil

    3/28/25 5:30:00 PM ET
    $CJMB
    Real Estate